Adenosine receptor agents and conditioned place preference

General Pharmacology

Volumn 29, Issue 2, 1997, Pages 285-289

  Zarrindast, M R ^a   Moghadamnia, A A ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

8 PT; CHA; Conditioned place aversion; Conditioned place preference; NECA; R PIA; Theophylline

Indexed keywords

8 PHENYLTHEOPHYLLINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; CYCLOHEXYLADENOSINE; PHENYLISOPROPYLADENOSINE; THEOPHYLLINE;

ANIMAL EXPERIMENT; ARTICLE; AVERSIVE BEHAVIOR; CONDITIONING; CONTROLLED STUDY; DRUG ANTAGONISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL;

ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANIMALS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; PHENYLISOPROPYLADENOSINE; RECEPTORS, PURINERGIC P1; THEOPHYLLINE;

EID: 0030878675     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00236-4     Document Type: Article

References (44)

1. Aulisi E. F. and Hoebel B. G. (1983) Rewarding effects of amphetamine and cocaine in the nucleus accumbens and block by fulpenthixol. Soc. Neurossci. Abastr. 9, 121.
2. Barraco R. A., Coffin V. L., Altman H. J. and Phillis J. W. (1983) Central effects of adenosine analogs on locomotor activity in mice and antagonism of caffeine. Brain Res. 272, 392-395.
3. Blisky E. J., Montegol M. J., Delong C. L. and Reid L. D. (1992) Opioidergic modulation of cocaine conditioned preferences. Life Sci. 50, 85-90.
4. 3H]phenylxanthine. Proc. Natl. Acad. Sci. USA 77, 5547-5555.
5. 3H] NECA in rat striatal membranes. Molec. Pharmacol. 29, 331-346.
6. Carr G. D. and White N. M. (1983) Conditioned place preference from intra-accumbens but not intra-caudate amphetamine injections. Life Sci. 33, 2551-2557.
7. Choi O. H., Shamim M. T., Padgett W. L. and Daly J. W. (1988) Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor agonists and as phosphodiesterase inhibitors. Life Sci. 43, 387-398.
8. Coffin V. L. and Spealman R. D. (1985) Modulation of the behavioral effects of chlor-diazepoxide by methylxanthines and analogs of adenosine in squirrel monkeys. J. Pharmacol. Exp. Ther. 235, 724-728.
9. Coffin V. L., Tatlor J. A., Phillis J. W., Altman H. J. and Barraco R. A. (1984) Behavioral interaction of adenosine and methylxanthines on central purinergic systems. Neurosci. Lett. 47, 91-98.
10. Daly J. W. (1982) Adenosine receptors: targets for future drugs. J. Med. Chem. 25, 197-207.
11. Di Chiara G. and North R. A. (1992) Neurobiology of opiate abuse. Trends Pharmac. Sci. 13, 185-193.
12. Dunwiddie, T. V. (1985) The physiological role of adenosine in the central nervous system. Int. Rev. Neurobiol. 27, 63-139.
13. Dunwiddie T. V. and Worth T. (1982) Sedative and anticonvulsant effects of adenosine analogs in mouse and rat. J. Pharmacol. Exp. Ther. 220, 70-76.
14. Ferre S., Herra-Marschitz M., Grabowska-Anden M., Casas M., Ungerstedt U. and Anden N. E. (1991) Post synaptic dopamine/adenosine interaction: II. Post synaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice. Eur. J. Pharmacol. 192, 31-37.
15. Hamilton H. W., Taylor M. D., Steffen R. P., Haleen S. J. and Bruns R. F. (1987) Correlation of adenosine receptor affinities and cardiovascular activity. Life Sci. 41, 2295-2302.
16. Harms H. H., Wardeh G. and Mulder A. H. (1980) Effects of adenosine on depolarization induced release of various radio labelled neurotransmitters from slices of rat corpus striatum. Neuropharmacol. 18, 577-580.
17. Heffner T. G., Wiley J. N., Williams A., Bruns R. F. and Coughenour L. L. (1989) Comparison of the behavioural effects of adenosine agonists and dopamine antagonists in mice. Psychopharmacol. 98, 31-37.
18. Jacobson K. A., Galen P. J. M. and Williams M. (1992) Adenosine receptors: Pharmacology, structure-activity relationships and therapeutics potential. J. Med. Chem. 35, 407-420.
19. Koob G. F. (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13, 176-184.
20. Levine A. S. and Morely J. E. (1982) Purinergic regulation of food intake. Science 217, 77-79.
21. Londos C., Cooper D. M. F. and Wolff J. (1980) Subclasses of external adenosine receptors. Proc. Natl. Acad. Sci. USA 77, 2251-2254.
22. Myers S. and Pugsley T. A. (1986) Decrease in rat striatal dopamine synthesis and metabolism in vivo by metabolically stable adenosine receptor agonists. Brain Res. 375, 193-197.
23. Petcoff D. W. and Cooper D. M. F. (1987) Adenosine receptor agonists inhibit inositol phosphate accumulation in rat striatal slices. Eur. J. Pharmacol. 137, 269-271.
24. Sabetkasai M. and Zarrindast M. R. (1993) Antinociception: interaction between adenosine and GABA systems. Arch. Int. Pharmacodyn. 322, 14-22.
25. Sawynok J., Sweeny M. I. and White T. D. (1989) Adenosine release may mediate spinal analgesia by morphine. Trends Pharmacol. Sci. 10, 186-189.
26. Sawynok J., Espey M. J. and Reid A. (1991) 8-Phenyltheophylline reverses the antinociceptive action of morphine in the periaqueductal gray. Neuropharmacol. 30, 871-877.
27. Smellie F. W., Davis C. W., Daly J. W. and Wells J. N. (1979) Alkylxanthines: Inhibition of adenosine elicited accumulation of cAMP in brain slices and brain phosphodiesterase activity. Life Sci. 24, 2475-2482.
28. Snyder S. H. (1985) Adenosine as a neural modulator. Annu. Rev. Neurosci. 8, 103-124.
29. Snyder S. H., Katims J. J., Annau Z., Bruns R. F. and Daly J. W. (1981) Adenosine receptors and the behavioral actions of methylxanthines. Proc. Natl. Acad. Sci. USA 78, 3260-3264.
30. Spanagel R., Herz A., Blas-Kubik R. and Shippenberg T. S. (1991) β-endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens. Psychopharmacol. 104, 51-56.
31. Spyraki C., Fibiger H. C. and Phillips A. G. (1982) Dopaminergic substrates of amphetamine-induced place preference conditioning. Brain Res. 253B, 185-193.
32. Taylor M. D., Moos W. H., Hamilton H. W., Szotek D. S., Patt W. C., Badger E. W., Bristol J. A., Bruns R. F., Heffner T. G. and Mertz T. E. (1986) Ribose-modified adenosine analogues as adenosine receptor agonists. J. Med. Chem. 29, 346-353.
33. Van Calker D., Muller M. and Hamprecht B. (1979) Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 33, 999-1005.
34. Vapaatalo H., Onken D., Neuvonen P. J. and Westermann E. (1975) Sterospecificity in some central circulatory effects of phenylisopropyl-adenosine (PIA). Drug Res. 25, 407-410.
35. Weis O. F., Shriwatanakul K., Allosa J. L., Weintraub, M. and Lasagna L. (1983) Attitudes of patients, housestaff, and nurses toward post-operative analgesic care. Anesth. Analg. 62, 70-74.
36. Yarbrough G. C. and McGuffin-Clineschmidt J. C. (1981) In vivo behavioral assessment of central nervous system purinergic receptors. Eur. J. Pharmacol 76, 137-144.
37. Zarrindast M. R. and Nasir T. (1991) Methylaxanthine-induced attenuation of pecking in chickens. Br. J. Pharmacol. 104, 327-330.
38. Zarrindast M. R. and Nikfar S. (1994) Different influences of adenosine receptor agonists and antagonists on morphine antinociception in mice. Gen. Pharmacol. 25, 139-142.
39. Zarrindast M. R. and Poursoltan M. (1989) Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced apomorphine, bromocriptine or physostigmine Br. J. Pharmacol 96, 843-848.
40. Zarrindast M. R. and Sharifzadeh M. (1995) Effects of adenosine drugs on apomorphine-induced licking in rats. Gen. Pharmacol. 26, 1119-1123.
41. 2 receptor activation in rats. Br. J. Pharmacol. 105, 675-678.
42. Zarrindast M. R., Sabetkasai M. and Khakpour S. (1993) Effects of drug active at adenosine receptors on stress-induced analgesia in mice. Arch. Int. Pharmacodyn. 325, 51-60.
43. Zarrindast M. R., Mamanpush S. M. and Rashidy-Pour S. M. (1994) Morphine inhibits dopaminergic and cholinergic induced ejaculation in rats. Gen. Pharmacol. 25, 803-808.
44. Zarrindast M. R., Fatehi F. and Mohagheghi-Badi M. (1995) Effects of adenosine agents on apomorphine-induced yawning in rats. Psychoparmacol. 122, 292-296.